Summary Stage 2018: Larynx Subglottic
Summary Stage 2018
Notes
Larynx Subglottic
8000-8700
C322
C322 Subglottis
Note 1: The following sources were used in the development of this chapter
- SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
- SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
- Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
- Chapter 13 Larynx, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
Note 2: See the following chapters for the listed histologies
- 8710-8714, 8800-8934, 8940-9138, 9141-9582: Soft Tissue
- 8720-8790: Melanoma Head and Neck
- 8935-8936: GIST
- 9140: Kaposi Sarcoma
- 9700-9701: Mycosis Fungoides
Note 3: Impaired vocal cord mobility, also described as vocal cord paresis, may suggest invasion of intrinsic laryngeal muscle. Fixation of the vocal cord may be described as immobility of the arytenoids noted on endoscopy, vocal cord paralysis, or deviation of larynx to fixed side.
Note 4: Code 1 for localized tumor only if no information is available to identify further extension.
Note 5: Tumor limited to the larynx (code 1) includes tumor involving, but limited to, the supraglottis, glottis and subglottis.
NAACCR Item
NAACCR #764SS2018 | Description |
---|---|
0 | In situ: noninvasive, intraepithelial |
1 | Localized only (localized, NOS)
|
2 | Regional by direct extension only
Invasion of
|
3 | Regional lymph node(s) involved only
|
4 | Regional by BOTH direct extension AND regional lymph node(s) involved
|
7 | Distant site(s)/lymph node(s) involved
|
9 | Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998), National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). SEER Summary Staging Manual-2000: Codes and Coding Instructions, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05. American Joint Committee on Cancer (Chicago, IL)
(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. Principles of Cancer Staging. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
(5) Lydiatt, W.M., Patel, S.G., Shah, J.P., et al. Staging Head and Neck Cancers. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017
(6) Patel, S.G., Lydiatt, W.M., Shah, J.P., et al. Larynx. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017